Literature DB >> 12415533

Relation between depression and anxiety in dystonic patients: implications for clinical management.

E Moraru1, P Schnider, A Wimmer, T Wenzel, P Birner, H Griengl, E Auff.   

Abstract

Past clinical research has identified depression as the most common psychiatric disorder associated with cervical dystonia (CD). The purpose of our study is to document different patterns of psychopathology, the frequency of psychiatric disorders, and possible correlation with the neurological disorder in patients with CD. Forty patients with CD were investigated to assess levels of psychopathology on two self-rated scales: the Beck Depression Inventory (BDI) and Symptom Check List (SCL-90). To determine the presence of psychiatric disorders, the patients were evaluated using the standard instrument in the DSM-III-R (Structured Clinical Interview Schedule, SCID). A small group of dystonic patients (12%) had higher levels of psychopathology, with significant amounts of concomitant anxiety and depression on the BDI and SCL-90. SCID criteria for at least one psychiatric disorder were fulfilled in 22 patients (55%), including both the lifetime and current diagnoses. The most frequent diagnostic categories were anxiety (40%) and major depressive disorders (37.5%). In 17 patients (42.5%), criteria for at least one lifetime diagnosis were fulfilled prior to the onset of CD. Psychiatric evaluation does not indicate one specific disorder associated with CD. The presence of anxiety and depression symptoms before and during the course of dystonia, without a possible causal relationship, could mean that the alteration of a chain of physiological events in the central nervous system may not lead to a single clinical picture. The relatively high overall lifetime prevalence of anxiety and depressive disorders may indicate the need for a broader diagnostic and therapeutic approach to patients with focal dystonia. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415533     DOI: 10.1002/da.10039

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  24 in total

1.  [Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].

Authors:  B Leplow; M Böttcher; R Schönfeld
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 2.  Nonmotor manifestations of dystonia: a systematic review.

Authors:  Daniel J Kuyper; Veronica Parra; Shanae Aerts; Michael S Okun; Benzi M Kluger
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

3.  Obsessive-compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene.

Authors:  Gary A Heiman; Ruth Ottman; Rachel J Saunders-Pullman; Laurie J Ozelius; Neil J Risch; Susan B Bressman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-04-05       Impact factor: 3.568

4.  Psychiatric disorders in idiopathic-isolated focal dystonia.

Authors:  Alexander Lehn; George Mellick; Richard Boyle
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

5.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

6.  [Botulinum toxin treatment : therapy success in cases of depression and ongoing pension applications].

Authors:  A Bachhuber; G Reichel; M Doberenz; A Stenner; W Hermann
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

7.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

8.  Mood and energy determinants of quality of life in dystonia.

Authors:  Anne Soeder; Benzi M Kluger; Michael S Okun; Cynthia W Garvan; Thomas Soeder; Charles E Jacobson; Ramon L Rodriguez; Rick Turner; Hubert H Fernandez
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

Review 9.  Psychiatric comorbidities in dystonia: emerging concepts.

Authors:  Mateusz Zurowski; William M McDonald; Susan Fox; Laura Marsh
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

10.  Depression in focal, segmental and generalized dystonia.

Authors:  L Lewis; A Butler; M Jahanshahi
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.